Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
The Daily Times, a daily newspaper in Tennessee, and Hastings Tribune, a daily newspaper in Nebraska, highlighted a study published in the July issue of The American Journal of Managed Care® (AJMC®). The study, “Differences in Spending on Provider-Administered Chemotherapy by Site of Care in Medicare,” found that spending on chemotherapy drugs was lower among Medicare beneficiaries who received chemotherapy in hospital outpatient departments than among comparable beneficiaries receiving chemotherapy in physician offices.
A study published in the February issue of AJMC®, “ACA Marketplace Premiums and Competition Among Hospitals and Physician Practices,” was mentioned in an article from Albany Business Review. The study concluded that premiums in federally facilitated Affordable Care Act Health Insurance Marketplaces are higher in geographic areas with more concentrated hospitals and physician practices and fewer insurers.
The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed included an article from AJMC® on person-centered care. The article, “Integrating Person-Centered Care and Evidence-Based Research at Hospitals Caring for Vulnerable Populations,” reported on a new road map from America’s Essential Hospitals that highlights how to overcome barriers to integrating person-centered care and evidence-based research at hospitals caring for vulnerable populations.
Putting a spotlight on the increasing amount of funds going toward medical health research in the United States, an article from AJMC® covered a report that found a 20.6% growth in spending from 2013 to 2016. The article, “Report: US Medical Health Research Spending on the Rise, but for How Long?,” was included in an article from Banyan Hill, an outlet dedicated to investment news.
An article from Pew Trusts on antibiotic use in retail health clinics acknowledged a study from the April 2015 issue of AJMC®, “Antibiotic Prescribing for Respiratory Infections at Retail Clinics, Physician Practices, and Emergency Departments.” The study, noting concerns that retail clinics provide inferior quality of care, found that there were no differences in the quality of care among the 3 sites of care.
FDA Expands Access to Approved CAR T-Cell Therapies by Eliminating REMS
June 30th 2025The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for approved chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, aiming to ease provider burden and expand patient access.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen